Clinical data from patients with glioblastoma

LHA-ID
7Q0CG2J3VH-7
Motivation

The prognostic value of different molecular predictors on overall and progression free survival was investigated.

Description
Progression free survival and overall survival of patients with glioblastoma dependent on TP53 mutation, p53 immunoreactivity, epidermal growth factor receptor, cyclin-dependent kinase CDK 4 or murine double minute 2 amplification, CDKN2A homozygous deletion, allelic losses on chromosome arms 1p, 9p, 10q, and 19q, O6-methylguanine methyltransferase (MGMT) promoter methylation, and isocitrate dehydrogenase 1 (IDH1) mutations
Study Design

Fresh-frozen tissue and blood samples were obtained from 301 patients with microsurgical tumor resection and clinical
follow-up information was collected.

Publication Date
Contact
Bettina Hentschel
Contact Institution

IMISE
Härtelstr. 16-18
04107 Leipzig

Version Number
1.0
Sample Size
n=301
Human Disease Ontology Concept